Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii

被引:146
|
作者
Vila, J
Ruiz, J
Goni, P
deAnta, TJ
机构
[1] Department of Microbiology, School of Medicine, University of Barcelona, 08036 Barcelona
[2] Laboratorio de Microbiologia, Hospital Clínic, Universitat de Barcelona, 08036 Barcelona, Villarroel
关键词
D O I
10.1093/jac/39.6.757
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Mutations in the parC gene, which encodes a subunit of topoisomerase IV, were determined in 21 epidemiologically unrelated clinical isolates of Acinetobacter baumannii. Our studies highlight the conserved sequences in the quinolone-resistance-determining region of the parC gene from A. baumannii and other bacteria. Nine of ten isolates with MICs of ciprofloxacin of greater than or equal to 32 mg/L showed a change of Ser80 to Leu and one showed a change of Glu84 to Lys. These results suggest that ParC from A. baumannii is a secondary target for quinolones and that mutations at residues Ser80 and Glu84, when combined with mutations at Ser83 of GyrA, may render A, baumannii highly resistant to quinolones.
引用
收藏
页码:757 / 762
页数:6
相关论文
共 50 条
  • [1] Detection of quinolone-resistance mutations of parC gene in clinical isolates of Acinetobacter baumannii in Iran
    Vakili, Bahareh
    Khorvash, Farzin
    Fazeli, Hossein
    Khaleghi, Moj
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (06): : 567 - 570
  • [2] Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU
    Liu, Yen-Hung
    Kuo, Shu-Chen
    Lee, Yi-Tzu
    Chang, Ian C. Y.
    Yang, Su-Pen
    Chen, Te-Li
    Fung, Chang-Phone
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2012, 45 (02) : 108 - 112
  • [3] Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene
    Kumagai, Y
    Kato, J
    Hoshino, K
    Akasaka, T
    Sato, K
    Ikeda, H
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) : 710 - 714
  • [4] Development of highly ciprofloxacin-resistant laboratory mutants of Acinetobacter baumannii lacking topoisomerase IV gene mutations
    Hamouda, A
    Amyes, SGB
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (01) : 155 - 156
  • [5] Association between mutations in gyrA and parC genes of Acinetobacter baumannii clinical isolates and ciprofloxacin resistance
    Ardebili, Abdollah
    Lari, Abdolaziz Rastegar
    Beheshti, Maryam
    Lari, Elnaz Rastegar
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2015, 18 (06) : 623 - 626
  • [6] Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of Acinetobacter baumannii
    Wisplinghoff, H
    Decker, M
    Haefs, C
    Krut, O
    Plum, G
    Seifert, H
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) : 177 - 179
  • [7] A fluoroquinolone-resistant Acinetobacter baumannii without the quinolone resistance-determining region mutations
    Chopra, Sidharth
    Galande, Amit
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (11) : 2668 - 2670
  • [8] Interactions of established and novel antibacterials with Acinetobacter baumannii gyrase and topoisomerase IV
    Joshi, Samika
    Byl, Jo Ann
    Osheroff, Neil
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S39 - S39
  • [9] Insertion sequence disruption of adeR and ciprofloxacin resistance caused by efflux pumps and gyrA and parC mutations in Acinetobacter baumannii
    Lopes, B. S.
    Amyes, S. G. B.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (02) : 117 - 121
  • [10] Evaluation of Ciprofloxacin (gyrA, parC Genes) and Tetracycline (tetB Gene) Resistance in Nosocomial Acinetobacter baumannii Infections
    Nowroozi, Jamileh
    Sepahi, Abbas Akhavan
    Kamarposhti, Lida Tahmasebinejad
    Razavipour, Roya
    Mazhar, Flor
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2014, 7 (02)